ABVC BioPharma Inc

Research ABVC BioPharma Inc (ABVC) on Bullrun: market cap USD 40.82M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerABVC
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 40.82M
• Financial periodFY2025
• RevenueUSD 296.00K
• Revenue growth-41.9%
• Net income-USD 7.91M

Valuation Snapshot

latest market cap is USD 40.82M.

About ABVC BioPharma Inc

ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer; ABV-1504, which has completed Phase II clinical trials for depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder;

Frequently asked questions

What is ABVC BioPharma Inc's market cap?

ABVC BioPharma Inc's market capitalization is USD 40.82M.

What does ABVC BioPharma Inc do?

ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer;